Carson, William E. IV
Major, Samantha
Akkineni, Harshitha
Fung, Hannah
Peters, Elias
Carpenter, Kimberly L. H.
Dawson, Geraldine
Carlson, David E.
Funding for this research was provided by:
National Institutes of Health (P50HD093074, P50HD093074, P50HD093074)
Brain & Behavior Research Foundation 23807 (NARSAD Young Investigator Grant)
Office of the Assistant Secretary of Defense for Health Affairs (Autism Research Program W81XWH-14-1-0526)
Marcus Foundation
Article History
Received: 11 July 2024
Accepted: 15 October 2024
First Online: 25 October 2024
Declarations
:
: Conflicts of interest of the authors of this manuscript are as follows: Dr. Geraldine Dawson is on the Scientific Advisory Boards of Akili, Inc, Nonverbal Learning Disability Project, and Tris Pharma, Inc., provided consultation to Apple, Inc., Gerson Lehrman Group, and Guidepoint Global, LLC, received speaker fees from WebMD and book royalties from Guilford Press, Oxford University Press, Springer Nature Press. Dr. Dawson reports grant funding from NICHD, NIMH, and the Simons Foundation; Dr. Dawson has patents 16/493,754, 15/141,391, and 16/678,789. Dr. Dawson has developed technology, data, and/or products that have been licensed to Apple, Inc. and Cryocell, Inc. and Dr. Dawson and Duke University have benefited financially. All the remaining authors declare no conflict of interest.